Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 489 of 6351
-
New stent trial aims to stop second strokes in Hard-to-Treat carotid disease
Disease control Recruiting nowGoal is to analyse the clinical safety and efficacy of the CARESTO® heal Stent within standard clinical routine for the treatment of patients with symptomatic non-stenotic carotid disease (SyNC) and with high-risk plaque features for stroke recurrence compared to medical treatmen…
Sponsor: Acandis GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for leukemia patients: experimental drug combo enters late-stage trial
Disease control Not yet recruitingThis study is an open, multicenter, dose-escalation and expansion, non-randomized phase II/III clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-M11D1 in combination with cytarabine + daunorubicin or venetoclax + …
Phase 2/3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New scope surgery may improve outcomes for babies with meningitis complications
Disease control Not yet recruitingGlobally, approximately 750,000 cases of infantile meningitis occur annually\[1\]. Clinical data show infantile postmeningitis subdural fluid collection (IPSFC) is the most common complication of infantile bacterial meningitis (IBM), with a progression rate of 30-60% (39% in stan…
Sponsor: Shengjing Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Stem cells could save sight after chemical burns
Disease control Not yet recruitingSevere chemical burns of the eye are serious injuries that can cause intense inflammation of the ocular surface and destroy limbal epithelial stem cells, which are essential for corneal healing. These injuries may lead to severe vision loss, blindness, or even loss of the eye des…
Phase 2 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug cocktail targets tough lung cancer mutation
Disease control Not yet recruitingThis study evaluates the safety, tolerability, maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and recommended phase II dose (RP2D) of Glecirasib in combination with Ivonescimab in patients with previously untreated, KRAS G12C-mutated, locally advanced or metastati…
Phase 1/2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Tumor avatars could personalize sarcoma therapy
Disease control By invitation onlyThis study is a prospective single arm multicenter intervention study aimed at evaluating the feasibility of using organoid drug sensitivity results to guide first-line treatment of advanced leiomyosarcoma. The primary endpoint of the study is objective response rate (ORR). The s…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New Immunotherapy-Chemo cocktail targets stomach cancer
Disease control Not yet recruitingA prospective, single-arm, multicenter, Phase II clinical study of Apatolimab Tovolimab (QL1706) in combination with modified FLOT regimen (TFOX) as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Spinal stimulation + rehab aims to restore walking in spinal cord injury
Disease control Not yet recruitingInterventional prospective longitudinal on the evaluation of spinal cord stimulation (SCS) assisted by motor rehabilitation training for restoring motor function in patients with non-traumatic spinal cord injury (SCI). The investigators will enroll ten research participants with …
Sponsor: Albano Luigi • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug takes on T-DXd in breast cancer showdown
Disease control Not yet recruitingThis is a single-center, randomized, open-label, phase II interventional study. Eligible patients will be randomized 1:1 to receive either Trastuzumab-rezetecan (4.8 mg/kg Q3W) or T-DXd (5.4 mg/kg Q3W) for 8 neoadjuvant cycles. After completing neoadjuvant treatment, patients wil…
Phase 2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Experimental cocktail aims to neutralize deadly grain fumigant poisoning
Disease control Not yet recruitingMetal phosphides are commonly utilized for safeguarding stored grains due to their desirable characteristics. They have high potency and the ability to combat different pests and produce non-toxic residues in crops . In countries like Iran, India, and Egypt, metal phosphides are…
Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New stem cell combo aims to stop lymphoma from spreading to the brain
Disease control Recruiting nowIn the era of novel therapeutic agents, high-dose conditioning chemotherapy combined with autologous hematopoietic stem cell transplantation (auto-HSCT) remains an important and feasible consolidation strategy for non-Hodgkin lymphoma, especially for high-risk and relapsed/refrac…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Triple therapy aims to turn inoperable bowel cancer into surgical candidates
Disease control Not yet recruitingTo evaluate the efficacy and safety of immune checkpoint inhibitor-based combination therapy with targeted therapy and chemotherapy in patients with locally advanced unresectable or metastatic colorectal cancer.
Phase 4 • Sponsor: Ye Xu • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
AI could solve thyroid nodule mystery: new study aims to predict cancer risk
Diagnosis Recruiting nowThe prospective study aim to develop a multimodal deep learning model that integrates ultrasound images and cytological whole-slide images for more accurate malignant risk prediction of Bethesda III thyroid nodules.
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Massive heart surgery trial aims to slash infection rates
Prevention Not yet recruitingThe goal of this pragmatic, multi-centre factorial cluster randomized cross-over trial is to assess the efficacy of a combination of cefazolin plus vancomycin compared to cefazolin monotherapy, as well as a comparison of short versus long-term prophylaxis with four study arms: 1)…
Phase 4 • Sponsor: Hamilton Health Sciences Corporation • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
New hope for mild stroke: Clot-Buster may help when time is lost
Disease control Not yet recruitingTo verify the efficacy and safety of intravenous tenecteplase (TNK) in patients with disabling minor stroke and large vessel occlusion (LVO) within a 4.5-24 hour time window.
Phase 3 • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New cocktail aims to outsmart deadly colorectal cancer
Disease control Recruiting nowColorectal cancer (CRC) is the second leading cause of cancer-related death globally. BRAF V600E mutations occur in approximately 12% of metastatic CRC (mCRC) patients, conferring an extremely poor prognosis with a median overall survival (OS) of only 11 months for standard chemo…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
First human test of gene injection into vagus nerve for fatal childhood disease
Disease control Recruiting nowGiant axonal neuropathy (GAN) is a rare pediatric disorder caused by autosomal recessive mutations in the GAN gene. GAN is a multisystem, neurodegenerative disorder affecting the peripheral nervous system (PNS), central nervous system (CNS) and autonomic nervous system (ANS). GA…
Phase 1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart surgery for athletes: does zapping faulty signals boost or bust performance?
Disease control Recruiting nowThe relationship between exercise and atrial fibrillation (AF) seems to follow a J-shaped curve: while moderate activity reduces AF risk, both insufficient and excessive endurance exercise increase susceptibility. In athletes, standard treatments such as antiarrhythmic drugs ofte…
Sponsor: University Hospital of Leuven Leuven • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Jump higher, sprint faster? a new training combo puts basketball power to the test
Disease control CompletedThis randomized controlled trial evaluated the effects of 12 weeks of French Contrast Training (FCT) compared with traditional resistance training (RT) on lower-limb explosive performance in male collegiate basketball players. Forty participants were randomly assigned in a 1:1 ra…
Sponsor: Ziren Zhao • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a single drug dose make repeat hypospadias surgery safer?
Disease control OngoingThis study aims to fill that gap by evaluating the efficacy and safety of intravenous TXA in children undergoing redo hypospadias surgery, potentially establishing a new standard of care
Sponsor: Aswan University Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC